Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) Non Operating Income (2016 - 2025)

Medifast (MED) has disclosed Non Operating Income for 16 consecutive years, with -$4.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non Operating Income rose 3.37% year-over-year to -$4.1 million, compared with a TTM value of $3.1 million through Dec 2025, up 158.91%, and an annual FY2025 reading of $3.1 million, up 178.51% over the prior year.
  • Non Operating Income was -$4.1 million for Q4 2025 at Medifast, down from $2.8 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $3.6 million in Q1 2024 and bottomed at -$4.2 million in Q4 2024.
  • Average Non Operating Income over 5 years is -$23050.0, with a median of $1500.0 recorded in 2021.
  • The sharpest move saw Non Operating Income plummeted 10242.86% in 2022, then soared 10375.0% in 2023.
  • Year by year, Non Operating Income stood at $7000.0 in 2021, then tumbled by 10242.86% to -$710000.0 in 2022, then surged by 404.08% to $2.2 million in 2023, then tumbled by 296.29% to -$4.2 million in 2024, then grew by 3.37% to -$4.1 million in 2025.
  • Business Quant data shows Non Operating Income for MED at -$4.1 million in Q4 2025, $2.8 million in Q3 2025, and $2.6 million in Q2 2025.